AMPK Activator Licensing Deal Highlights Successful Collaboration Between Boston-based Mercury Therapeutics, Inc. and CreaGen Biosciences

BOSTON--(BUSINESS WIRE)--The recent licensing deal between Mercury Therapeutics and Debiopharm showcases the highly successful partnership between Mercury Therapeutics and CreaGen Biosciences, said CreaGen in a statement released today.